The link and numbers above are primarily about NNT/NNH for neuropathic pain, and it references an older Cochrane review from 2006. The updated version is from 2013.
Opioids for neuropathic pain. - PubMed - NCBI
I think you're mixing acute vs chronic treatment with opioids with acute vs chronic pain treatment, as it is rare outside of things like PHN to have an acute neuropathic pain state, which was the initial question and the quoted numbers; but sure, I totally agree with what you're saying with regards to COT for pain in terms of the data.
Cancer pain's gotten so much tougher to treat as folks don't end up dead in a few months to a year anymore.
I'd argue that we'd be remiss if a young woman with focal cancer associated pain was on chronic
systemic opioid therapy in lieu of chronic
intrathecal opioid therapy, especially when we can do better. The slam dunk is the intervention, as stimulation wouldn't allow focal coverage for both a neuropathic and nociceptive pain and would likely benefit from a paddle lead to reliably cover the elbow/arm for someone who presumably is looking at 10 - 50 years of therapy.
We could argue about the right IT medications like we could stim patterns, but I'm fine with any or all, and love having the option to escalate if necessary. It's part of the reason I avoid one trick ponies like Nevro and reserve Bioness' PNS for simple things; limitations suck.
Regardless, I'm assuming they're already on a combination of anti-depressants, anti-epileptics, systemic or topical NSAIDs, and systemic opioids managed by the OP. But maybe no one follows the WHO ladder anymore and we're just stimming/pumping early to avoid medications?